InsiderClue
Stocks · Health care · Pharmaceutical Preparations

NOVARTIS AG

NVS Clue Score67
Switzerland Fiscal year ends December CIK 0001114448
$143.84 +0.06% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $143.84 +75.46% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 13 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2016Operating income8.27Net income6.71EPS, diluted2.80Fiscal year 2017Operating income8.70Net income7.70 +14.8%EPS, diluted3.25 +16.1%Fiscal year 2018Operating income8.40Net income12.61 +63.7%EPS, diluted5.38 +65.5%Fiscal year 2019Operating income9.09Net income11.73 −7.0%EPS, diluted5.06 −5.9%Fiscal year 2020Operating income10.15Net income8.07 −31.2%EPS, diluted3.52 −30.4%Fiscal year 2021Operating income10.06Net income24.02 +197.6%EPS, diluted10.63 +202.0%Fiscal year 2022Operating income7.95Net income6.96 −71.0%EPS, diluted3.17 −70.2%Fiscal year 2023Operating income9.77Net income14.85 +113.5%EPS, diluted7.10 +124.0%Fiscal year 2024Operating income14.54Net income11.94 −19.6%EPS, diluted5.87 −17.3%Fiscal year 2025Operating income17.64Net income13.98 +17.1%EPS, diluted7.15 +21.8%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating income 8.27 8.70 8.40 9.09 10.15 10.06 7.95 9.77 14.54 17.64
Net income 6.71 7.70 12.61 11.73 8.07 24.02 6.96 14.85 11.94 13.98
Growth +14.8% +63.7% −7.0% −31.2% +197.6% −71.0% +113.5% −19.6% +17.1%
EPS, diluted 2.80 3.25 5.38 5.06 3.52 10.63 3.17 7.10 5.87 7.15
Growth +16.1% +65.5% −5.9% −30.4% +202.0% −70.2% +124.0% −17.3% +21.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow11.48Capital expenditure−1.86Free cash flow9.61Buybacks−1.11Dividends paid−6.48Fiscal year 2017Operating cash flow12.62Capital expenditure−1.33Free cash flow11.30 +17.5%Buybacks−5.49Dividends paid−6.50Fiscal year 2018Operating cash flow14.27Capital expenditure−1.25Free cash flow13.02 +15.2%Buybacks−2.04Dividends paid−6.97Fiscal year 2019Operating cash flow13.63Capital expenditure−1.38Free cash flow12.25 −5.9%Buybacks−5.53Dividends paid−6.65Fiscal year 2020Operating cash flow13.65Capital expenditure−1.28Free cash flow12.38 +1.1%Buybacks−2.84Dividends paid−6.99Fiscal year 2021Operating cash flow15.07Capital expenditure−1.07Free cash flow14.01 +13.2%Buybacks−3.06Dividends paid−7.37Fiscal year 2022Operating cash flow14.24Capital expenditure−0.92Free cash flow13.32 −4.9%Buybacks−10.65Dividends paid−7.51Fiscal year 2023Operating cash flow14.46Capital expenditure−1.06Free cash flow13.40 +0.6%Buybacks−8.72Dividends paid−7.26Fiscal year 2024Operating cash flow17.62Capital expenditure−1.37Free cash flow16.25 +21.3%Buybacks−8.33Dividends paid−7.62Fiscal year 2025Operating cash flow19.14Capital expenditure−1.55Free cash flow17.60 +8.3%Buybacks−9.21Dividends paid−7.82
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 11.48 12.62 14.27 13.63 13.65 15.07 14.24 14.46 17.62 19.14
Capital expenditure −1.86 −1.33 −1.25 −1.38 −1.28 −1.07 −0.92 −1.06 −1.37 −1.55
Free cash flow 9.61 11.30 13.02 12.25 12.38 14.01 13.32 13.40 16.25 17.60
Growth +17.5% +15.2% −5.9% +1.1% +13.2% −4.9% +0.6% +21.3% +8.3%
Buybacks −1.11 −5.49 −2.04 −5.53 −2.84 −3.06 −10.65 −8.72 −8.33 −9.21
Dividends paid −6.48 −6.50 −6.97 −6.65 −6.99 −7.37 −7.51 −7.26 −7.62 −7.82

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash7.01Total debt0.18Net cash (debt)6.83Shareholders’ equity74.83Debt to equity0.00Fiscal year 2017Cash8.86Total debt0.36Net cash (debt)8.50Shareholders’ equity74.17Debt to equity0.00Fiscal year 2018Cash13.27Total debt3.19Net cash (debt)10.08Shareholders’ equity78.61Debt to equity0.04Fiscal year 2019Cash11.11Total debt2.00Net cash (debt)9.11Shareholders’ equity55.47Debt to equity0.04Fiscal year 2020Cash9.66Total debt2.27Net cash (debt)7.39Shareholders’ equity56.60Debt to equity0.04Fiscal year 2021Cash12.41Total debt2.62Net cash (debt)9.79Shareholders’ equity67.66Debt to equity0.04Fiscal year 2022Cash7.52Total debt2.24Net cash (debt)5.28Shareholders’ equity59.34Debt to equity0.04Fiscal year 2023Cash13.39Total debt2.19Net cash (debt)11.20Shareholders’ equity46.67Debt to equity0.05Fiscal year 2024Cash11.46Total debt3.36Net cash (debt)8.10Shareholders’ equity44.05Debt to equity0.08Fiscal year 2025Cash11.44Total debt0.79Net cash (debt)10.64Shareholders’ equity46.13Debt to equity0.02
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 7.01 8.86 13.27 11.11 9.66 12.41 7.52 13.39 11.46 11.44
Total debt 0.18 0.36 3.19 2.00 2.27 2.62 2.24 2.19 3.36 0.79
Net cash (debt) 6.83 8.50 10.08 9.11 7.39 9.79 5.28 11.20 8.10 10.64
Shareholders’ equity 74.83 74.17 78.61 55.47 56.60 67.66 59.34 46.67 44.05 46.13
Debt to equity 0.00 0.00 0.04 0.04 0.04 0.04 0.04 0.05 0.08 0.02

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In billions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
17.52 13.63 14.51 14.43 15.12 11.74 11.58 12.47 12.83 13.70
31.92 29.77 31.59 34.25 34.78 32.24 31.88 34.19 38.90 42.98
Growth −6.7% +6.1% +8.4% +1.5% −7.3% −1.1% +7.2% +13.8% +10.5%
9.04 8.39 8.49 9.40 8.98 8.64 9.17 11.37 10.02 11.20
14.19 12.47 13.72 14.37 14.20 12.83 12.19 12.52 12.57 13.25
8.27 8.70 8.40 9.09 10.15 10.06 7.95 9.77 14.54 17.64
Growth +5.2% −3.4% +8.1% +11.7% −0.9% −21.0% +22.9% +48.9% +21.3%
7.82 9.10 14.10 8.94 9.88 24.53 7.18 9.12 13.64 16.35
1.12 1.60 1.30 1.79 1.81 1.63 1.13 0.55 1.70 2.39
6.71 7.70 12.61 11.73 8.07 24.02 6.96 14.85 11.94 13.98
Growth +14.8% +63.7% −7.0% −31.2% +197.6% −71.0% +113.5% −19.6% +17.1%
Per share
2.82 3.28 5.44 5.12 3.55 10.71 3.19 7.15 5.92 7.21
2.80 3.25 5.38 5.06 3.52 10.63 3.17 7.10 5.87 7.15
Growth +16.1% +65.5% −5.9% −30.4% +202.0% −70.2% +124.0% −17.3% +21.8%
2,378 2,346 2,319 2,291 2,277 2,243 2,181 2,077 2,018 1,939
2,400 2,371 2,344 2,319 2,296 2,260 2,197 2,092 2,035 1,955
Growth −1.2% −1.1% −1.1% −1.0% −1.6% −2.8% −4.8% −2.7% −3.9%

Five years in brief

Worked out from the figures above, not from a press release
  • The diluted share count fell 14.9% in five years, so buybacks did some of the work per share.
  • Profitable in every one of the 10 years on file.